Violetta Cotreau
Nessuna posizione attualmente
Profilo
Violetta Cotreau worked as the Chief Accounting Officer & Senior Vice President at Akebia Therapeutics, Inc. from 2020 to 2022.
Prior to that, she was the Senior Vice President & Controller at AMAG Pharmaceuticals, Inc. from 2016 to 2020.
She completed her undergraduate degree at the University of Massachusetts Lowell.
Precedenti posizioni note di Violetta Cotreau
| Società | Posizione | Fine |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 30/12/2022 |
| AMAG PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/11/2020 |
Formazione di Violetta Cotreau
| University of Massachusetts Lowell | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Borsa valori
- Insiders
- Violetta Cotreau
